Correlation Between Vera Therapeutics and TC BioPharm
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and TC BioPharm Holdings, you can compare the effects of market volatilities on Vera Therapeutics and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and TC BioPharm.
Diversification Opportunities for Vera Therapeutics and TC BioPharm
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vera and TCBP is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and TC BioPharm go up and down completely randomly.
Pair Corralation between Vera Therapeutics and TC BioPharm
Given the investment horizon of 90 days Vera Therapeutics is expected to generate 0.32 times more return on investment than TC BioPharm. However, Vera Therapeutics is 3.09 times less risky than TC BioPharm. It trades about -0.18 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.34 per unit of risk. If you would invest 4,141 in Vera Therapeutics on December 27, 2024 and sell it today you would lose (1,550) from holding Vera Therapeutics or give up 37.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 96.67% |
Values | Daily Returns |
Vera Therapeutics vs. TC BioPharm Holdings
Performance |
Timeline |
Vera Therapeutics |
TC BioPharm Holdings |
Vera Therapeutics and TC BioPharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vera Therapeutics and TC BioPharm
The main advantage of trading using opposite Vera Therapeutics and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.Vera Therapeutics vs. Third Harmonic Bio | Vera Therapeutics vs. Cullinan Oncology LLC | Vera Therapeutics vs. Edgewise Therapeutics | Vera Therapeutics vs. Rallybio Corp |
TC BioPharm vs. ZyVersa Therapeutics | TC BioPharm vs. Palisade Bio | TC BioPharm vs. Unicycive Therapeutics | TC BioPharm vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |